World Library  
Flag as Inappropriate
Email this Article

Delayed puberty

Delayed puberty
Classification and external resources
ICD-10 E30.0
ICD-9-CM 259.0
DiseasesDB 17462
MeSH D011628

Puberty is described as delayed puberty with exceptions when an organism has passed the usual age of onset of puberty with no physical or hormonal signs that it is beginning. Puberty may be delayed for several years and still occur normally, in which case it is considered constitutional delay, a variation of healthy physical development. Delay of puberty may also occur due to malnutrition, many forms of systemic disease, or to defects of the reproductive system (hypogonadism) or the body's responsiveness to sex hormones.


  • Normal timing 1
  • Evaluation 2
    • Lateness 2.1
    • Discordance 2.2
    • Indications of specific disorders 2.3
  • Possible causes 3
  • Constitutional delay 4
  • Medical evaluation 5
  • Management 6
  • See also 7
  • References 8

Normal timing

Approximate mean ages for the onset of various pubertal changes are as follows. Ages in parentheses are the approximate 3rd and 97th percentiles for attainment. For example, less than 3% of girls have not yet achieved thelarche by 13 years of age. Developmental changes during puberty in girls occur over a period of 3 – 5 years, usually between 10 and 15 years of age. They include the occurrence of secondary characteristics beginning with breast development, the adolescent growth spurt, the onset of menarche – which does not correspond to the end of puberty – and the acquisition of fertility, as well as profound psychological modifications.

The normal variation in the age at which adolescent changes occur is so wide that puberty cannot be considered to be pathologically delayed until the menarche has failed to occur by the age of 18 or testicular development by the age of 20.

For North American, Indo-Iranian (India, Iran) and European girls For North American, Indo-Iranian (India, Iran) and European boys
  • Thelarche (breast development) 10.0y5m (8y–13y)
  • Pubarche (pubic hair) 11y (8.5–13.5y)
  • Growth spurt 11.25y (10–12.5y)
  • Menarche (first menstrual bleeding) 12.5y (10.5–14.5y)
  • Adult height reached 15.5y (?-?)
  • Gonadarche (testicular enlargement) 11.5y (9.5–13.5y)
  • Pubarche (pubic hair) 12y (10–14y)
  • Growth spurt 14y (11-17y)
  • Completion of growth 17y (15-20y)

The sources of the data, and a fuller description of normal timing and sequence of pubertal events, as well as the hormonal changes that drive them, are provided in the principal article on puberty. It is worthwhile to consider the world geographical and ethnographic/demographic limits and deficits of this study.


There are three indications that pubertal delay may be due to an abnormal cause.


The first is simply degree of lateness: although no recommended age of evaluation cleanly separates pathologic from physiologic delay, a delay of 2–3 years or more warrants evaluation.

  • In girls, no breast development by 13 years, or no menarche by 3 years after breast development (or by 16).
  • In boys, no testicular enlargement by 14 years, or delay in development for 5 years or more after onset of genitalia enlargement.

A delay of two standard deviations has been proposed as a standard.[1]


The second indicator is discordance of development. In most children, puberty proceeds as a predictable series of changes in specific order. In children with ordinary constitutional delay, all aspects of physical maturation typically remain concordant but a few years later than average. If some aspects of physical development are delayed, and others are not, it is likely that something is wrong.

  • For instance, in most girls, the beginning stages of breast development precede pubic hair. If a 12-year-old girl were to reach Tanner stage 3 pubic hair for a year or more without breast development, it would be unusual enough to suggest an abnormality such as defective ovaries.
  • Similarly, if a 13-year-old boy had reached stage 3 or 4 pubic hair with testes that still remained prepubertal in size, it would be unusual and suggestive of a testicular abnormality.

Indications of specific disorders

The third indicator is the presence of clues to specific disorders of the reproductive system.

Possible causes

Constitutional delay

Children who are healthy but have a slower rate of physical development than average have constitutional delay in growth and adolescence. These children have a history of stature shorter than their age-matched peers throughout childhood, but their height is appropriate for bone age, and skeletal development is delayed more than 2.5 SD. They usually are thin and often have a family history of delayed puberty. Children with a combination of a family tendency toward short stature and constitutional delay are the most likely to seek evaluation. They quite often seek evaluation when classmates or friends undergo pubertal development and growth, thereby accentuating their delay.

Medical evaluation

Pediatric endocrinologists are the physicians with the most training and experience evaluating delayed puberty. A complete medical history, review of systems, growth pattern, and physical examination will reveal most of the systemic diseases and conditions capable of arresting development or delaying puberty, as well as providing clues to some of the recognizable syndromes affecting the reproductive system.

Since bone maturation is a good indicator of overall physical maturation, an x-ray of the hand to assess bone age usually reveals whether the child has reached a stage of physical maturation at which puberty should be occurring. Visible secondary sexual development usually begins when girls achieve a bone age of 10.5 to 11 years, and boys achieve a bone age of 11.5 to 12 years.

The most valuable blood tests are the gonadotropins, because elevation confirms immediately a defect of the gonads or deficiency of the sex steroids. In many instances, screening tests such as a complete blood count, general chemistry screens, thyroid tests, and urinalysis may be worthwhile.

More expensive and complicated tests, such as a karyotype or magnetic resonance imaging of the head, are usually obtained only when specific evidence suggests they may be useful.

Use of gonadotropin releasing hormone can be of value in the differential diagnosis.[7]

If delayed puberty is accompanied with a lack of sense of smell (anosmia) or a history of un-descended testicles (cryptorchidism) when born then a diagnosis of Kallmann syndrome could be considered.[8][9]


If a child is healthy but simply late, reassurance and prediction based on the bone age can be provided. No other intervention is usually necessary. In more extreme cases of delay, or cases where the delay is more extremely distressing to the child, a low dose of testosterone or estrogen for a few months may bring the first reassuring changes of normal puberty.

If the delay is due to systemic disease or undernutrition, the therapeutic intervention is likely to focus mainly on those conditions.

If it becomes clear that there is a permanent defect of the reproductive system, treatment usually involves replacement of the appropriate hormones (testosterone/dihydrotestosterone for boys,[10] estradiol and progesterone for girls).

Pubertal delay due to gonadotropin deficiency is treated with testosterone replacement or with HCG.[2]

Growth hormone is another option that has been described.[11][12]

Subnormal vitamin A intake is one of the aetiological factors in delayed pubertal maturation. Supplementation of both vitamin A and iron to normal constitutionally delayed children with subnormal vitamin A intake is as efficacious as hormonal therapy in the induction of growth and puberty.[13]

See also


  1. ^ Traggiai C, Stanhope R (2003). "Disorders of pubertal development". Best Pract Res Clin Obstet Gynaecol 17 (1): 41–56.  
  2. ^ a b c Marianne J. Legato, ed. (2004) "Principles of Gender-Specific Medicine, Volume 1-2", ISBN 0-12-440905-9, p. 22
  3. ^ a b Greenspan, FS; Gardner DG (2004). "Puberty". Basic & Clinical Endocrinology. pp. 617–627.  
  4. ^ Johannesson M, Gottlieb C, Hjelte L (1997). "Delayed puberty in girls with cystic fibrosis despite good clinical status". Pediatrics 99 (1): 29–34.  
  5. ^ Layman LC, Lee EJ, Peak DB, et al. (1997). "Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene". N. Engl. J. Med. 337 (9): 607–11.  
  6. ^ Chan WK, To KF, But WM, Lee KW (June 2006). "Frasier syndrome: a rare cause of delayed puberty". Hong Kong Med J 12 (3): 225–7.  
  7. ^ Jungmann E, Trautermann C (1994). "[The status of the gonadotropin releasing hormone test in differential diagnosis of delayed puberty in adolescents over 14 years of age]". Med. Klin. (Munich) (in German) 89 (10): 529–33.  
  8. ^ Oxford Endocrinology Library. Testosterone Deficiency in Men. 2008. ISBN 978-0199545131 Editor: Hugh Jones. Chapter 9. Puberty & Fertility.
  9. ^ Male Hypogonadism. Friedrich Jockenhovel. Uni-Med Science. 2004. ISBN 3-89599-748-X. Chapter 3. Diagnostic work up of hypogonadism.
  10. ^ Saad RJ, Keenan BS, Danadian K, Lewy VD, Arslanian SA (October 2001). "Dihydrotestosterone treatment in adolescents with delayed puberty: does it explain insulin resistance of puberty?". J. Clin. Endocrinol. Metab. 86 (10): 4881–6.  
  11. ^ Heinrichs C, Bourguignon JP (1991). "Treatment of delayed puberty and hypogonadism in girls". Horm. Res. 36 (3–4): 147–52.  
  12. ^ Massa G, Heinrichs C, Verlinde S, et al. (September 2003). "Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height". J. Clin. Endocrinol. Metab. 88 (9): 4168–74.  
  13. ^ Zadik Z, Sinai T, Zung A, Reifen R. (2004). "Vitamin A and iron supplementation is as efficient as hormonal therapy in constitutionally delayed children.". Clin Endocrinol (Oxf). 60 (6): 682–7.  
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.